Results for the First Quarter 2022

All-time high sales for a quarter ending at MNOK 116.1 (MNOK 102.6), an increase of 13.2%.

All-time high sales for a quarter ending at MNOK 116.1 (MNOK 102.6), an increase of 13.2%. Sales growth is driven by the USA with a currency-neutral increase of 34.2%. Currency neutral sales of own products increased by 10.9% for the quarter. Operating result (EBIT) for the quarter ended at MNOK 33.4 (MNOK 29.1), a 15.0% increase. EBIT margin was 28.8% (28.3%).

The General Meeting decided a dividend of NOK 3.75 per share, a total dividend payment of MNOK 68.4.

See the full presentation and report below as well as the recording from the webinar.

Q1 2022 presentation

Q1 2022 Financial Report

Name of cookie	Time of storage	Provider	Description
_ga	2 years	medistim.com	This cookie registers your unique ID upon your visit, to generate statistical data on how you use our website.
_gat	1 day	medistim.com	This cookie is used by Google Analytics to throttle the request rate.
_gid	1 day	medistim.com	This cookie registers a unique ID that is used to generate statistical data on how you use our website.
p.gif	Session	typekit.net	This cookie keeps track of special fonts used on the site for internal analysis. This cookie does not register any visitor data.

Name of cookie	Time of storage	Provider	Description
ads/ga.audiences	Session	google.com	This cookie is used by Google Adwords to re-engage visitors that are likely to convert to customers based on the visitor's online behaviour across websites
r/collect	Session	doubleclick.net	This cookie is used to send data to Google Analytics about the visitor's device and behavior. The cookie tracks visitors across devices and marketing channels.